Literature DB >> 30583215

Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis.

Farimah Masoumi1, Samira Ghorbani2, Farideh Talebi2, William G Branton3, Samira Rajaei1, Christopher Power4, Farshid Noorbakhsh5.   

Abstract

In this study, we investigated the contributions of the MALAT1 long noncoding RNA to autoimmune neuroinflammation in central nervous system tissues from patients with multiple sclerosis (MS) and mice with experimental autoimmune encephalomyelitis (EAE). Expression of MALAT1 was decreased in the spinal cords of EAE mice as well as in stimulated splenocytes and primary macrophages. MALAT1 downregulation by specific siRNAs enhanced the polarization of macrophages towards the M1 phenotype. Interestingly, siRNA-mediated MALAT1 downregulation shifted the pattern of T-cell differentiation towards a Th1/Th17 cell profile and decreased differentiation towards a Tregs phenotype. Proliferation of T-cells was also increased following MALAT1 downregulation. These data point to a potential anti-inflammatory effect for MALAT1 in the context of autoimmune neuroinflammation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Experimental autoimmune encephalomyelitis (EAE); Long noncoding RNA; MALAT1; Multiple sclerosis (MS)

Mesh:

Substances:

Year:  2018        PMID: 30583215     DOI: 10.1016/j.jneuroim.2018.11.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  26 in total

Review 1.  The Expanding Regulatory Mechanisms and Cellular Functions of Long Non-coding RNAs (lncRNAs) in Neuroinflammation.

Authors:  Shraddha Tripathi; Bakhya Shree; Stuti Mohapatra; Anirban Basu; Vivek Sharma
Journal:  Mol Neurobiol       Date:  2021-02-08       Impact factor: 5.590

2.  SMILR Aggravates the Progression of Atherosclerosis by Sponging miR-10b-3p to Regulate KLF5 Expression.

Authors:  Huaqing Li; Zhiyu Pan; Qian Chen; Zhen Yang; Dongbing Zhang
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 3.  Cardiovascular inflammation: RNA takes the lead.

Authors:  Colton R Martens; Shyam S Bansal; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000

Review 4.  The role of non-coding RNAs in neuroinflammatory process in multiple sclerosis.

Authors:  Anna Nowak; Zofia Wicik; Marta Wolska; Andleeb Shahzadi; Piotr Szwed; Joanna Jarosz-Popek; Jeffrey Palatini; Marek Postula; Anna Czlonkowska; Dagmara Mirowska-Guzel; Ceren Eyileten
Journal:  Mol Neurobiol       Date:  2022-05-19       Impact factor: 5.682

Review 5.  Long Noncoding RNAs as Orchestrators of CD4+ T-Cell Fate.

Authors:  Chang Liu; Yanli Zhang; Zhanchuan Ma; Huanfa Yi
Journal:  Front Cell Dev Biol       Date:  2022-06-20

Review 6.  Nucleic Acids as Novel Therapeutic Modalities to Address Multiple Sclerosis Onset and Progression.

Authors:  Hussein Baharlooi; Amir Hossein Mansourabadi; Moein Minbashi Moeini; Leila Mohamed Khosroshahi; Maryam Azimi
Journal:  Cell Mol Neurobiol       Date:  2021-10-25       Impact factor: 4.231

Review 7.  lncRNAs in T lymphocytes: RNA regulation at the heart of the immune response.

Authors:  Leah M Plasek; Saba Valadkhan
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-09       Impact factor: 4.249

Review 8.  LncRNAs in adaptive immunity: role in physiological and pathological conditions.

Authors:  Pedro Faria Zeni; Marek Mraz
Journal:  RNA Biol       Date:  2020-11-09       Impact factor: 4.652

9.  Malat1 Suppresses Immunity to Infection through Promoting Expression of Maf and IL-10 in Th Cells.

Authors:  James P Hewitson; Katie A West; Kylie R James; Gulab Fatima Rani; Nidhi Dey; Audrey Romano; Najmeeyah Brown; Sarah A Teichmann; Paul M Kaye; Dimitris Lagos
Journal:  J Immunol       Date:  2020-04-22       Impact factor: 5.422

10.  Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer.

Authors:  Miok Kim; Yong Ki Min; Jinho Jang; Hyejin Park; Semin Lee; Chang Hoon Lee
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.